{"title":"Molecular craftsmanship: reforging peptide backbones for enhanced drug design","authors":"Peng Zhang , Youjia Hao , Mengjun Xie , Huan Wang , Jiangtao Gao","doi":"10.1016/j.drudis.2025.104395","DOIUrl":null,"url":null,"abstract":"<div><div>This review analyzes peptide backbone modifications in drug design, examining fundamental principles and applications in pharmaceutical development. A systematic classification of modification approaches encompasses amide bond alterations, α-carbon modifications, backbone extensions and conformational constraints. The analysis evaluates synthetic methodologies, computational tools and biological outcomes, emphasizing clinical translation barriers. Critical examination of current design paradigms reveals systematic biases and unexpected effects while advancing theoretical frameworks incorporating multi-scale phenomena. The work addresses computational modeling limitations, regulatory requirements and production challenges, presenting evidence-based solutions. This integration of chemical, biological and computational perspectives provides a foundation for advancing peptide-based therapeutics.</div></div>","PeriodicalId":301,"journal":{"name":"Drug Discovery Today","volume":"30 7","pages":"Article 104395"},"PeriodicalIF":7.5000,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Discovery Today","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1359644625001084","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
This review analyzes peptide backbone modifications in drug design, examining fundamental principles and applications in pharmaceutical development. A systematic classification of modification approaches encompasses amide bond alterations, α-carbon modifications, backbone extensions and conformational constraints. The analysis evaluates synthetic methodologies, computational tools and biological outcomes, emphasizing clinical translation barriers. Critical examination of current design paradigms reveals systematic biases and unexpected effects while advancing theoretical frameworks incorporating multi-scale phenomena. The work addresses computational modeling limitations, regulatory requirements and production challenges, presenting evidence-based solutions. This integration of chemical, biological and computational perspectives provides a foundation for advancing peptide-based therapeutics.
期刊介绍:
Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed.
Features include comment by international experts, news and analysis of important developments, reviews of key scientific and strategic issues, overviews of recent progress in specific therapeutic areas and conference reports.